April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Interferon Beta Down-Regulates Cxcr3 on T Lymphocytes and Prevents Mice From Developing Immune-Mediated Ocular Inflammation
Author Affiliations & Notes
  • J. Chen
    Laboratory of Immunology, National Eye Inst/NIH, Bethesda, Maryland
  • C. Tan
    Laboratory of Immunology, National Eye Inst/NIH, Bethesda, Maryland
  • B. P. Vistica
    Laboratory of Immunology, National Eye Inst/NIH, Bethesda, Maryland
  • I. Gery
    Laboratory of Immunology, National Eye Inst/NIH, Bethesda, Maryland
  • B. Detrick
    Department of Pathology, Johns Hopkins University, Baltimore, Maryland
  • J. J. Hooks
    Laboratory of Immunology, National Eye Inst/NIH, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  J. Chen, None; C. Tan, None; B.P. Vistica, None; I. Gery, None; B. Detrick, None; J.J. Hooks, None.
  • Footnotes
    Support  Intramural Research Programs of NEI, NIH
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 818. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Chen, C. Tan, B. P. Vistica, I. Gery, B. Detrick, J. J. Hooks; Interferon Beta Down-Regulates Cxcr3 on T Lymphocytes and Prevents Mice From Developing Immune-Mediated Ocular Inflammation. Invest. Ophthalmol. Vis. Sci. 2010;51(13):818.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : IFN-beta can possess immunosuppressive activity and has been used in the treatment of diseases with a cerebral inflammation component such as multiple sclerosis. Although little has been done to investigate the mechanism, it has been suggested by our group that a critical role for RPE cell-derived IFN-beta in the down-regulation of CXCL9 protects retina from excessive inflammation (J Immunol 2008,180:3789). In this study we elucidated the immunoregulatory effects of IFN-beta on T cell CXCR3 expression in vitro and in a mouse model of Th1-mediated ocular inflammation, in which CXCR3 and its chemokines are critical for disease development.

Methods: : Th cells expressing a hen egg lysozyme (HEL)-specific TCR were polarized in vitro by activation with HEL in the presence of type-specific cytokines and antibodies. Ocular inflammation was induced in HEL transgenic mice expressing HEL in the lens by adoptive transfer of Th1 cells. IFN-beta was administrated daily intraperitoneally into recipient mice. Protein and gene expression of CXCR3 was determined on T cells. Disease levels were assessed histologically.

Results: : IFN-beta down-regulated CXCR3 on CD4+ and CD8+ T cells (particularly on Th1 cells), in association with an increased CXCL10 signaling. Importantly, IFN-beta down-regulated CXCR3 on migratory Th1 cells in the spleen of recipient mice, that blocked T cells trafficking into the target eyes and prevented mice from developing Th1-mediated ocular inflammation. The decline in CXCR3 expression by migratory Th1 cells was determined by FACS analyses, associated with an IFN-beta induced CXCR3 chemokine signaling cascade in the spleen.

Conclusions: : Our data demonstrate that the immunosuppression of IFN-beta seen in the mouse model of immune-mediated ocular inflammation is associated with re-navigation of T cell trafficking via IFN-beta mediated down-regulation of CXCR3. These observations therefore reveal a novel role of IFN-beta in the transduction of CXCR3 signaling for T cell migration.

Keywords: autoimmune disease • cytokines/chemokines • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×